Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner

The broader Nasdaq was under pressure Monday morning.
Vaccine stocks like Novavax, Moderna, and Ocugen, however, did quite well.
Moreover, one biotech stock managed to top even the strong performance from vaccine stocks.